Hepatology

bt_bb_section_bottom_section_coverage_image
https://mylinbiotech.com/wp-content/uploads/2023/08/Association-of-hepatitis-C-virus-infection-and-malnutrition.png
Hepatology

Association of Hepatitis C Virus Infection and Malnutrition: Inflammation Complex Syndrome in Maintenance Hemodialysis Patients

Our research highlights the severe health issues faced by hemodialysis patients with active HCV infections, including increased morbidity and mortality. Specific metabolic abnormalities associated with HCV in this context were also discovered. Identifying optimal treatment strategies for these patients is crucial for improved care.
https://mylinbiotech.com/wp-content/uploads/2023/08/Hepatology-5.png
Hepatology

Microbiota and the Gut-Liver Axis: Bacterial Translocation, Inflammation, and Infection in Cirrhosis

Our study explores the factors contributing to liver cirrhosis, with viral hepatitis and alcohol consumption being key causes. We observed a significant occurrence of malnutrition in 67% of patients, particularly among older individuals with advanced disease severity. Notably, malnourished patients faced a higher risk of complications. These findings emphasize the critical relationship between malnutrition and adverse outcomes in liver cirrhosis.
https://mylinbiotech.com/wp-content/uploads/2023/08/GUT.png
Hepatology

Gut Microbiota and Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD, a prevalent liver condition linked to metabolic syndrome, poses a significant health concern globally. Our study delved into the fascinating interplay between gut bacteria and NAFLD development. Compelling evidence highlights the role of gut bacteria in obesity, internal ethanol production, inflammation, and choline metabolism. These findings pave the way for targeted interventions to effectively manage NAFLD and its complications.
https://mylinbiotech.com/wp-content/uploads/2023/08/Hepatology-2.png
Hepatology

Meta-analysis: Impact of Probiotic Type, Dose, and Duration on Irritable Bowel Syndrome (IBS) Diagnosed by Rome III Criteria

With 11.2% of the global population affected by IBS, finding effective treatments is crucial. Our comprehensive meta-analysis examined various probiotic types, doses, and treatment durations for IBS patients. The results unveiled the power of probiotics as a pharmacological therapy, particularly when single probiotics are administered at a low dose and for a short duration. These findings empower individuals seeking effective solutions to manage IBS symptoms and improve their overall quality of life.